Shotgun proteomics to study anti-jumbo phage immunity by AVAST
Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Pseudomonas Aeruginosa Mpao1/p1
SUBMITTER: 
Martin Pabst
LAB HEAD: Martin Pabst
PROVIDER: PXD065050 | Pride | 2025-12-15
REPOSITORIES: Pride
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| MP13112023_L1_DDA01.mzXML | Mzxml | |||
| MP13112023_L1_DDA01.raw | Raw | |||
| MP13112023_L2_DDA01.mzXML | Mzxml | |||
| MP13112023_L2_DDA01.raw | Raw | |||
| MP13112023_L3_DDA01.mzXML | Mzxml |
Items per page: 5 1 - 5 of 20 |
Similar Datasets
Project description:To investigate the interactome of the human translocase of the outer mitochondrial membrane (TOM) complex, we performed immunoaffinity purification of TOMM22-FLAG from HEK293T cells followed by LC-MS/MS analysis. This approach allowed us to identify proteins that co-purify with the TOM complex under native conditions. Our primary aim was to uncover human-specific interactors not previously described in yeast, with a particular focus on factors potentially involved in mitochondrial protein import regulation and quality control. The dataset provides a resource for understanding conserved and divergent aspects of TOM complex composition and function in human cells.
2026-03-17 | PXD064520 | Pride
Project description:Characterization of therapeutic monoclonal antibodies used in the context of B-cell precursor acute lymphoblastic leukemia (BCP-ALL). IgA2 antibodies targeting CD38 were analyzed using LC-MS/MS. Mass analysis, peptide mapping and glycoprofiling were performed to confirm sequence integrity and post-translational modifications. The analysis supports preclinical evaluation of antibody-based immunotherapies and provides insights into glycosylation relevant for effector function.
2026-06-09 | PXD066660 | Pride
Project description:Precise characterization of proteins and proteoforms within the protein corona is essential for developing safer and more effective nanomedicines for diagnostic and therapeutic applications. Although the protein corona phenomenon has been recognized in nanomedicine for nearly two decades, the application of top-down proteomics to analyze proteoforms within this context has only recently gained traction. In this study, we advance proteoform-level analysis of the protein corona by integrating mass spectrometry (MS)-based top-down proteomics (TDP) and bottom-up proteomics (BUP). To demonstrate the performance of this approach, we generated large TDP and BUP datasets of protein corona of polystyrene nanoparticles (PSNPs) by analyzing breast cancer human plasma samples at various stages.
2026-05-14 | PXD077545 | Pride
Project description:We derived two transgenic mouse lines expressing a T6B peptide either in the whole cytoplasm or targeted at the post-synapse, in order to perform AGO-APP directly from mouse tissues. We used these mice first to compare the expression of AGO-bound micro-RNAs in 2 types of neuron, the olfactory bulb inhibitory interneurons and the cortical excitatory neurons, and second to analyze the post-synaptic targeting of micro-RNAs in these 2 neuron types.
2025-06-01 | E-MTAB-15124 | biostudies-arrayexpress
Project description:Endoplasmic reticulum-associated degradation (ERAD) is a critical protein quality control mechanism that also regulates lipid metabolism and calcium homeostasis. Dysregulation of ERAD and unfolded protein response underlies diseases including cancer, neurodegenerative disorders, and metabolic syndromes. Small molecule modulators of ERAD could enable mechanistic discovery and therapeutic intervention, but few have been identified. Using a high-content screening, we discovered several ERAD-modulating compounds, including NCATS-SM0225, an ERAD inhibitor that unexpectedly binds all three isoforms of VDAC, outer mitochondrial membrane proteins enriched at mitochondria-associated membranes. This led us to discover an essential role for VDACs in ERAD and ER-phagy. NCATS-SM0225 elevates cytosolic, ER, and mitochondrial calcium through calcium influx and IP3R–MCU activity. This calcium imbalance strengthens VDAC1–IP3R coupling and activates PERK, which phosphorylates STIM1 and drives degradation of key ERAD regulators. Loss of these components amplifies PERK signaling and selectively kills cancer cells while sparing normal cells. These findings uncover a cancer-specific role of VDACs in ERAD regulation and calcium signaling, highlighting a therapeutically actionable vulnerability.
2026-01-20 | PXD071546 | Pride
Project description:This project aimed to identify differentially expressed proteins between tumor-associated macrophages (TAMs) and monocyte-derived macrophages (MDMs), both obtained from hepatocellular carcinoma (HCC) patients. Macrophages were isolated from tumor tissues and matched peripheral blood, respectively. Proteins were extracted and analyzed by mass spectrometry to characterize their distinct proteomic profiles. The results provide valuable insights into the molecular differences between TAMs and MDMs, contributing to a better understanding of macrophage function and regulation in the HCC tumor microenvironment.
2025-09-28 | PXD058385 | Pride
Project description:Myocardial hypertrophy and fibrosis (MHF) are key structural changes in adverse cardiac remodeling. They are commonly observed in hypertension, metabolic disorders, and cardiomyopathies. These processes contribute to heart failure and sudden death, yet their molecular mechanisms remain unclear. We established in vivo and in vitro models of MHF and performed transcriptomic and label-free phosphoproteomic sequencing. These data were integrated with public single-cell RNA sequencing datasets. This multi-tier strategy enabled us to move beyond bulk-tissue signals and prioritize candidates based on cross-omics concordance and cell-type-specific expression. We identified five candidate biomarkers, CLIP2, PLA2G4A, PRRX1, SLAIN2, and XPO1. These candidates showed coordinated upregulation or downregulation at both the transcriptomic and phosphoproteomic levels. They were also specifically enriched in disease-relevant cardiac cell populations, including cardiomyocytes and fibroblasts. PRRX1 and PLA2G4A were enriched in fibrogenic fibroblast subsets and increased along activation trajectories. XPO1 and SLAIN2 were downregulated in cardiomyocytes and fibroblasts, suggesting impaired nuclear export and cytoskeletal regulation. Molecular docking revealed flurandrenolide and selinexor as potential modulators of PLA2G4A and XPO1 respectively. However, their cardiovascular safety and efficiency remain uncertain. Notably, the therapeutic implications of XPO1 modulation appear context-dependent, warranting careful evaluation of its functional role in specific MHF etiologies. Overall, these findings highlight novel targets and provide mechanistic insights into MHF progression.
2026-06-15 | PXD076293 | Pride
Project description:Src homology 2 domain–containing inositol 5-phosphatase 1 (SHIP1), encoded by gene INPP5D, is a lipid phosphatase that negatively regulates immune receptor signaling in hematopoietic cells and microglia, which modulates downstream cellular proliferation, survival, and chemotaxis. Here, we report the optimization and characterization of a pyridyl–pyrazole-piperidine scaffold as a basis for SHIP1 ligands that demonstrate cellular target engagement, brain exposure, and evidence of a central pharmacodynamic response in vivo. Structure–activity relationship studies guided by biochemical and cellular assays using multiple human and murine SHIP1 protein constructs and cells identified compound 32 as a SHIP1-active ligand. To ensure that the cellular activity of compound 32 is not due to kinase inhibition in general within the context of BV2 mouse microglia cells, we executed a kinome profiling study of compound 32 compared to crizotinib as a positive control using BV2 cell lysates.
2026-04-03 | PXD071931 | Pride
Project description:Diatom-derived polyunsaturated aldehydes (PUAs) significantly influence marine bacterial dy-namics, yet the underlying proteomic mechanisms remain elusive. We employed high-resolution comparative proteomics to decipher the functional reprogramming of two bacterial communi-ties—one naturally associated with a PUA-producing diatom (N-community) and another with a non-PUA producer (I-community)—under ecologically relevant PUA exposure. While growth rates and cell densities remained unaffected, indicating an absence of acute toxicity, proteomics revealed pronounced community-specific reorganization. N-communities displayed stable, regula-tion-oriented adjustments consistent with physiological accommodation, whereas I-communities exhibited dose-dependent stress responses, shifting toward protein repair and antioxidant defense. Our findings demonstrate that PUAs trigger profound proteomic reprogramming conditioned by the communities' prior ecological history. This functional divergence provides a molecular basis for understanding bacterial fitness and succession during diatom blooms, where PUA-mediated in-teractions could act as a selective filter shaping the phycosphere's microbial landscape. Polyunsaturated aldehydes (PUA) produced by diatoms have been proposed to exert a wide range of effects on marine bacteria, from inhibitory or stress-inducing responses to neutral or potentially beneficial effects. However, the bacterial proteomic responses remain elusive. Here, we employed a high-resolution comparative proteomic approach to decipher the functional reprogramming of two distinct bacterial communities under ecologically relevant PUA exposure. One community was composed by bacteria naturally associated with a PUA-producing diatom (N- communy and, a second community associated with a non-PUA-producing diatom (I-community). Bacterial growth rates and final cell densities were not significantly affected by any treatment, indicating the absence of toxic effects even at high PUA concentrations. Dissolved organic carbon consumption did not provide evidence that PUA was the relevant carbon source. Interestingly, comparative proteomic analyses revealed pronounced community-specific reorganization in response to PUA expo-sure.Our results show that PUAs trigger a profound proteomic reprogramming rather than a simple stress response. While I-community prioritized antioxidant defense and protein repair, N-community showed a metabolic shift towards energy conservation. These findings suggest that the metabolic history of bacterial assemblages determines their success in the phycosphere, providing a molecular basis for microbial succession during diatom blooms.
2026-06-04 | PXD075100 | Pride
Project description:The SAGA transcriptional co-activator complex regulates gene expression through histone acetylation at promoters, mediated by its histone acetyl transferase, KAT2A. While its structure and function have been extensively investigated, how the stability of individual subunits of SAGA, including KAT2A, is regulated, remains unclear. Here, using a fluorescence-based KAT2A stability reporter, we systematically dissect the molecular dependencies controlling KAT2A protein abundance. We identify the non-enzymatic SAGA CORE module subunits—TADA1, TAF5L, and TAF6L— as necessary for KAT2A stability, with loss of these subunits disrupting the integrity of SAGA, leading to non-chromatin-bound KAT2A that is degraded by the proteasome, consequently leading to reduced H3K9 acetylation. Proteomic profiling reveals progressive loss of CORE and HAT components upon acute disruption of the SAGA CORE, indicating that an intact CORE is required for the stability of numerous components of SAGA. Finally, a focused CRISPR screen of ubiquitin-proteasome system genes identifies the E3 ligase UBR5, a known regulator of orphan protein degradation, and the deubiquitinase OTUD5, as regulators of KAT2A degradation when the SAGA CORE is perturbed. Together, these findings reveal a dependency of KAT2A protein stability on SAGA CORE integrity and define an orphan quality control mechanism targeting unassembled KAT2A, revealing a potential vulnerability in SAGA-driven malignancies.
2026-03-16 | PXD065443 | Pride